Kornitzer Capital Management Inc. KS Increases Stock Holdings in Xylem Inc (NYSE:XYL)

Kornitzer Capital Management Inc. KS increased its holdings in shares of Xylem Inc (NYSE:XYL) by 90.2% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 267,776 shares of the industrial products company’s stock after buying an additional 126,965 shares during the quarter. Kornitzer Capital Management Inc. KS owned 0.15% of Xylem worth $21,320,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also made changes to their positions in XYL. City Holding Co. grew its stake in Xylem by 116.7% during the 3rd quarter. City Holding Co. now owns 325 shares of the industrial products company’s stock valued at $26,000 after purchasing an additional 175 shares during the last quarter. FinTrust Capital Advisors LLC boosted its stake in shares of Xylem by 1,530.4% in the second quarter. FinTrust Capital Advisors LLC now owns 375 shares of the industrial products company’s stock worth $31,000 after buying an additional 352 shares during the last quarter. Winthrop Partners WNY LLC purchased a new stake in shares of Xylem in the third quarter worth about $32,000. Private Ocean LLC purchased a new stake in shares of Xylem in the second quarter worth about $33,000. Finally, Valeo Financial Advisors LLC boosted its stake in shares of Xylem by 500.0% in the third quarter. Valeo Financial Advisors LLC now owns 420 shares of the industrial products company’s stock worth $33,000 after buying an additional 350 shares during the last quarter. Hedge funds and other institutional investors own 84.81% of the company’s stock.

In related news, SVP Colin R. Sabol sold 4,099 shares of the company’s stock in a transaction dated Tuesday, October 1st. The stock was sold at an average price of $78.37, for a total value of $321,238.63. Following the completion of the transaction, the senior vice president now owns 33,518 shares of the company’s stock, valued at approximately $2,626,805.66. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Markos I. Tambakeras sold 2,860 shares of the stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $78.95, for a total value of $225,797.00. Following the transaction, the director now directly owns 43,530 shares of the company’s stock, valued at approximately $3,436,693.50. The disclosure for this sale can be found here. Insiders sold a total of 16,959 shares of company stock valued at $1,313,986 in the last ninety days. 0.85% of the stock is currently owned by insiders.

XYL has been the topic of a number of recent research reports. Zacks Investment Research downgraded Xylem from a “hold” rating to a “sell” rating and set a $82.00 target price on the stock. in a research note on Monday, October 14th. Credit Suisse Group set a $78.00 target price on Xylem and gave the stock a “hold” rating in a research note on Friday, November 1st. ValuEngine downgraded Xylem from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. Jefferies Financial Group initiated coverage on Xylem in a research note on Friday, September 20th. They issued a “buy” rating and a $90.00 target price on the stock. Finally, Seaport Global Securities downgraded Xylem from a “buy” rating to a “neutral” rating in a research note on Monday. One analyst has rated the stock with a sell rating, five have issued a hold rating and seven have given a buy rating to the company. The company presently has an average rating of “Hold” and a consensus target price of $82.30.

NYSE XYL traded down $0.13 during trading hours on Friday, reaching $77.19. The company’s stock had a trading volume of 643,533 shares, compared to its average volume of 971,026. The firm has a market capitalization of $14.35 billion, a price-to-earnings ratio of 26.80, a P/E/G ratio of 1.60 and a beta of 1.18. Xylem Inc has a 1-year low of $60.65 and a 1-year high of $85.67. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.55 and a quick ratio of 1.15. The company’s 50-day moving average is $78.72 and its two-hundred day moving average is $78.91.

Xylem (NYSE:XYL) last released its quarterly earnings results on Thursday, October 31st. The industrial products company reported $0.82 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.82. The company had revenue of $1.30 billion during the quarter, compared to analysts’ expectations of $1.33 billion. Xylem had a return on equity of 19.14% and a net margin of 9.65%. Xylem’s quarterly revenue was up .7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.77 EPS. Equities analysts forecast that Xylem Inc will post 3.02 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Thursday, December 5th. Investors of record on Thursday, October 31st will be issued a $0.24 dividend. The ex-dividend date of this dividend is Wednesday, October 30th. This represents a $0.96 dividend on an annualized basis and a yield of 1.24%. Xylem’s payout ratio is 33.33%.

Xylem Company Profile

Xylem Inc engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications. It operates in three segments: Water Infrastructure, Applied Water, and Measurement & Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation and treatment of water.

Featured Article: Stock Symbols, CUSIP and Other Stock Identifiers

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply